Justin Isaac Lowenthal, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stem Cell Research | 2 | 2015 | 37 | 0.870 |
Why?
|
Tissue Engineering | 5 | 2020 | 1865 | 0.820 |
Why?
|
Induced Pluripotent Stem Cells | 6 | 2020 | 1851 | 0.500 |
Why?
|
Organoids | 1 | 2020 | 744 | 0.450 |
Why?
|
Regenerative Medicine | 2 | 2015 | 306 | 0.410 |
Why?
|
Tetrahydronaphthalenes | 1 | 2012 | 86 | 0.400 |
Why?
|
Policy Making | 1 | 2015 | 541 | 0.370 |
Why?
|
Off-Label Use | 1 | 2012 | 185 | 0.360 |
Why?
|
Blood Vessels | 1 | 2015 | 1112 | 0.340 |
Why?
|
Biocompatible Materials | 2 | 2015 | 1683 | 0.340 |
Why?
|
Informed Consent | 2 | 2013 | 1007 | 0.320 |
Why?
|
Specimen Handling | 1 | 2012 | 701 | 0.290 |
Why?
|
Ethics, Medical | 1 | 2012 | 783 | 0.280 |
Why?
|
Education, Medical | 1 | 2019 | 1725 | 0.280 |
Why?
|
Drug Approval | 1 | 2012 | 812 | 0.250 |
Why?
|
Lung Diseases | 1 | 2015 | 1909 | 0.240 |
Why?
|
Myocardium | 4 | 2020 | 4725 | 0.220 |
Why?
|
Biomedical Research | 1 | 2019 | 3426 | 0.210 |
Why?
|
Stem Cells | 1 | 2015 | 3514 | 0.200 |
Why?
|
Myocytes, Cardiac | 3 | 2020 | 1667 | 0.200 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4058 | 0.200 |
Why?
|
Physicians | 1 | 2019 | 4583 | 0.180 |
Why?
|
Economics, Pharmaceutical | 1 | 2020 | 87 | 0.160 |
Why?
|
Arrhythmias, Cardiac | 2 | 2019 | 2234 | 0.160 |
Why?
|
Plakophilins | 1 | 2019 | 32 | 0.160 |
Why?
|
Cardiomyopathies | 2 | 2019 | 1948 | 0.140 |
Why?
|
Myocardial Contraction | 1 | 2020 | 1515 | 0.120 |
Why?
|
Hydrogels | 1 | 2020 | 720 | 0.110 |
Why?
|
Models, Cardiovascular | 1 | 2019 | 981 | 0.110 |
Why?
|
Medically Uninsured | 1 | 2018 | 835 | 0.100 |
Why?
|
Neovascularization, Physiologic | 1 | 2020 | 1349 | 0.100 |
Why?
|
Models, Immunological | 1 | 2015 | 512 | 0.100 |
Why?
|
Drug Costs | 1 | 2020 | 1183 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1086 | 0.100 |
Why?
|
Cystine | 1 | 2011 | 94 | 0.090 |
Why?
|
Polylysine | 1 | 2011 | 131 | 0.090 |
Why?
|
Antigen-Presenting Cells | 1 | 2015 | 963 | 0.090 |
Why?
|
Click Chemistry | 1 | 2011 | 95 | 0.090 |
Why?
|
Alzheimer Disease | 1 | 2012 | 8603 | 0.090 |
Why?
|
Anticarcinogenic Agents | 1 | 2012 | 249 | 0.090 |
Why?
|
Microcirculation | 1 | 2015 | 1272 | 0.090 |
Why?
|
Fibroblasts | 1 | 2020 | 4140 | 0.080 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2015 | 1492 | 0.080 |
Why?
|
Tissue Scaffolds | 1 | 2015 | 932 | 0.080 |
Why?
|
Embryonic Stem Cells | 1 | 2015 | 1262 | 0.080 |
Why?
|
Biological Specimen Banks | 1 | 2013 | 778 | 0.070 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1463 | 0.070 |
Why?
|
Drug Carriers | 1 | 2011 | 706 | 0.070 |
Why?
|
Stem Cell Transplantation | 1 | 2015 | 1600 | 0.070 |
Why?
|
Heart | 1 | 2019 | 4403 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2020 | 11512 | 0.060 |
Why?
|
Critical Care | 1 | 2018 | 2691 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18220 | 0.060 |
Why?
|
Folic Acid | 1 | 2011 | 1323 | 0.060 |
Why?
|
Cytokines | 1 | 2019 | 7373 | 0.060 |
Why?
|
Wound Healing | 1 | 2015 | 2802 | 0.060 |
Why?
|
United States Food and Drug Administration | 1 | 2012 | 1661 | 0.060 |
Why?
|
Nanoparticles | 1 | 2015 | 1957 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2015 | 3550 | 0.050 |
Why?
|
Humans | 14 | 2020 | 760740 | 0.050 |
Why?
|
Rats, Transgenic | 1 | 2019 | 69 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10759 | 0.040 |
Why?
|
Animals | 6 | 2019 | 168202 | 0.040 |
Why?
|
Swine | 2 | 2019 | 5908 | 0.040 |
Why?
|
Isoproterenol | 1 | 2019 | 397 | 0.040 |
Why?
|
Hospitalization | 1 | 2018 | 10708 | 0.040 |
Why?
|
Spheroids, Cellular | 1 | 2020 | 329 | 0.040 |
Why?
|
Maryland | 1 | 2018 | 277 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10175 | 0.040 |
Why?
|
Electrophysiological Phenomena | 1 | 2019 | 306 | 0.040 |
Why?
|
Poverty Areas | 1 | 2018 | 263 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 7995 | 0.030 |
Why?
|
Cardiotonic Agents | 1 | 2019 | 539 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2020 | 1336 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2019 | 1848 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7390 | 0.030 |
Why?
|
Mutation | 1 | 2019 | 30015 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1663 | 0.030 |
Why?
|
Action Potentials | 1 | 2019 | 1825 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1662 | 0.020 |
Why?
|
Micelles | 1 | 2011 | 192 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 506 | 0.020 |
Why?
|
United States | 2 | 2018 | 72292 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2019 | 2118 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2018 | 1187 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2011 | 1182 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1970 | 0.020 |
Why?
|
Mice | 1 | 2012 | 81368 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 1901 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18937 | 0.010 |
Why?
|
Cell Survival | 1 | 2011 | 5780 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2011 | 5863 | 0.010 |
Why?
|
Medicare | 1 | 2018 | 6774 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15577 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11458 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7873 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16968 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 59191 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 80583 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 13635 | 0.000 |
Why?
|
Female | 2 | 2018 | 392203 | 0.000 |
Why?
|
Aged | 1 | 2018 | 169092 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 2011 | 20988 | 0.000 |
Why?
|
Middle Aged | 1 | 2018 | 220603 | 0.000 |
Why?
|
Adult | 1 | 2018 | 220995 | 0.000 |
Why?
|
Male | 1 | 2018 | 360402 | 0.000 |
Why?
|